Doximity, Inc. (NASDAQ:DOCS) Holdings Reduced by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP decreased its position in Doximity, Inc. (NASDAQ:DOCSFree Report) by 0.7% in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 829,568 shares of the company’s stock after selling 6,174 shares during the period. Dimensional Fund Advisors LP owned approximately 0.45% of Doximity worth $23,262,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. First Horizon Advisors Inc. boosted its holdings in shares of Doximity by 111.3% in the fourth quarter. First Horizon Advisors Inc. now owns 995 shares of the company’s stock valued at $28,000 after acquiring an additional 524 shares in the last quarter. GAMMA Investing LLC bought a new position in shares of Doximity in the fourth quarter valued at approximately $40,000. Creative Financial Designs Inc. ADV boosted its holdings in shares of Doximity by 16.7% in the fourth quarter. Creative Financial Designs Inc. ADV now owns 3,301 shares of the company’s stock valued at $93,000 after acquiring an additional 473 shares in the last quarter. Neo Ivy Capital Management bought a new position in shares of Doximity in the third quarter valued at approximately $109,000. Finally, PNC Financial Services Group Inc. boosted its holdings in shares of Doximity by 16.6% in the third quarter. PNC Financial Services Group Inc. now owns 6,500 shares of the company’s stock valued at $138,000 after acquiring an additional 925 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

Insider Activity at Doximity

In other Doximity news, insider Craig Overpeck sold 1,500 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $23.85, for a total value of $35,775.00. Following the completion of the sale, the insider now owns 108,609 shares in the company, valued at approximately $2,590,324.65. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. In other Doximity news, insider Craig Overpeck sold 1,500 shares of the stock in a transaction that occurred on Thursday, May 16th. The shares were sold at an average price of $23.85, for a total value of $35,775.00. Following the completion of the sale, the insider now owns 108,609 shares in the company, valued at approximately $2,590,324.65. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Kira Scherer Wampler sold 2,500 shares of the stock in a transaction that occurred on Monday, April 1st. The stock was sold at an average price of $26.97, for a total transaction of $67,425.00. Following the completion of the sale, the director now owns 10,258 shares of the company’s stock, valued at approximately $276,658.26. The disclosure for this sale can be found here. In the last 90 days, insiders sold 6,500 shares of company stock worth $171,250. 39.40% of the stock is owned by corporate insiders.

Doximity Stock Performance

Shares of NASDAQ:DOCS opened at $27.64 on Tuesday. The company has a market cap of $5.13 billion, a PE ratio of 38.39, a price-to-earnings-growth ratio of 5.23 and a beta of 1.23. Doximity, Inc. has a 52 week low of $19.71 and a 52 week high of $36.29. The firm has a 50 day simple moving average of $25.70 and a 200 day simple moving average of $26.92.

Wall Street Analyst Weigh In

DOCS has been the subject of several recent analyst reports. Needham & Company LLC reiterated a “hold” rating on shares of Doximity in a report on Friday, May 17th. Leerink Partnrs reissued a “market perform” rating on shares of Doximity in a research note on Monday, February 26th. William Blair reissued an “outperform” rating on shares of Doximity in a research note on Friday, May 17th. JPMorgan Chase & Co. raised shares of Doximity from an “underweight” rating to a “neutral” rating and set a $25.00 target price for the company in a research note on Thursday, April 25th. Finally, Evercore ISI increased their target price on shares of Doximity from $28.00 to $29.00 and gave the company an “in-line” rating in a research note on Friday, May 17th. One investment analyst has rated the stock with a sell rating, eleven have given a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, Doximity has an average rating of “Hold” and a consensus target price of $28.73.

View Our Latest Stock Analysis on DOCS

Doximity Company Profile

(Free Report)

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.

Read More

Institutional Ownership by Quarter for Doximity (NASDAQ:DOCS)

Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.